Cargando…
Innate Immunity in Cancer Biology and Therapy
Immunotherapies including adaptive immune checkpoint inhibitors (ICIs) and chimeric antigen receptor (CAR) T cells, have developed the treatment of cancer in clinic, and most of them focus on activating T cell immunity. Although these strategies have obtained unprecedented clinical responses, only l...
Autores principales: | Zhang, Yuxia, Xue, Wenjing, Xu, Caili, Nan, Yanyang, Mei, Shuang, Ju, Dianwen, Wang, Shaofei, Zhang, Xuyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379825/ https://www.ncbi.nlm.nih.gov/pubmed/37510993 http://dx.doi.org/10.3390/ijms241411233 |
Ejemplares similares
-
Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer
por: Xu, Caili, et al.
Publicado: (2022) -
Targeting 4-1BB and PD-L1 induces potent and durable antitumor immunity in B-cell lymphoma
por: Wang, Yichen, et al.
Publicado: (2022) -
Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies
por: Nan, Yanyang, et al.
Publicado: (2023) -
Cell Membrane-Derived Vesicle: A Novel Vehicle for Cancer Immunotherapy
por: Xu, Caili, et al.
Publicado: (2022) -
Editorial: Community series in combinational immunotherapy of cancer: novel targets, mechanisms, and strategies, volume II
por: Xu, Caili, et al.
Publicado: (2023)